Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

NCT00335140 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

NETWORK

Sponsor class

Stopped slow accrual

Conditions

Lymphoma

Interventions

BIOLOGICAL: Rituximab
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Leucovorin
DRUG: Methotrexate
DRUG: Procarbazine
DRUG: Vincristine

Sponsor

Eastern Cooperative Oncology Group